Article
NBS1 Glu185Gln polymorphism and cancer risk: update on current evidence.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Jan 2014
He Ya-Zhou, Chi Xiao-Sa, Zhang Yuan-Chuan, Deng Xiang-Bing, Wang Jia-Rong, Lv Wen-Yu, Zhou Yan-Hong, Wang Zi-Qiang
Abstract excerpt
A number of studies have investigated the association between NBS1 Glu185Gln (rs1805794, E185Q) polymorphism and cancer risk, but the results remained controversial. Previous meta-analysis found a borderline significant impact of this polymorphism on cancer risk; however, the result might be relatively unreliable due to absence of numerous newly published studies. Thus, we conducted an updated meta-analysis. A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
